Novo Nordisk CEO rakes in cash in record year
Being at the top of Denmark’s most valuable company is lucrative, Novo Nordisk reveals in its annual report – and Chief Executive Lars Fruergaard Jørgensen is making a killing there.
by andreas lønstrup, translated by daniel pedersen
Novo Nordisk Chief Executive Lars Fruergaard Jørgensen presented on Wednesday an annual report for the Danish drugmaker showing growth across the board.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Novo Nordisk doubles obesity sales in 2022
For subscribers
.jpg&w=384&q=75)
